Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Authors: Yue Shi, Mei Dong, Xiaoting Hong, Wen Zhang, J. Feng, Jing-Zhong Zhu, Li Yu, Xiao Ke, He Huang, Z. Shen, Yun Fan, W. Li, Xiaohong Zhao, Jianyong Qi, He Huang, Daobin Zhou, Zhengwen Ning, Xianping Lu - Annals of Oncology 2015 cited by 396